Tamoxifen, associated to the conservative CKD treatment, promoted additional antifibrotic effect on experimental hypertensive nephrosclerosis
C. Fanelli, F. M. Ornellas, G. A. Celestrino, D. N. Carmagnani, A. L. Francini, I. L. Noronha
This study shows that combining tamoxifen with standard CKD treatment reduces hypertension, albuminuria, and fibrosis in experimental hypertensive nephrosclerosis.
bioRxiv · Oct 13, 2022Physiology